Ignite Creation Date:
2024-05-06 @ 8:13 PM
Last Modification Date:
2024-10-26 @ 3:23 PM
Study NCT ID:
NCT06304350
Status:
RECRUITING
Last Update Posted:
2024-03-13
First Post:
2024-02-21
Brief Title:
Pembrolizumab Combined With Preoperative Chemotherapy Albumin PaclitaxelCarboplatin Neoadjuvant Therapy for Resectable Locally Advanced Stage IIIII Esophageal Squamous Cell Carcinoma
Sponsor:
Tongji University
Organization:
Tongji University
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-02-17
Start Date Type:
ACTUAL
Primary Completion Date:
2026-02-25
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-12-31
Completion Date Type:
ESTIMATED
First Submit Date:
2024-02-21
First Submit QC Date:
March 4 2024
Study First Post Date:
2024-03-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-03-11
Last Update Post Date:
2024-03-13
Last Update Post Date Type:
ACTUAL